Literature DB >> 11224834

Medical consumption and socioeconomic effects of infection with respiratory syncytial virus in The Netherlands.

C J Miedema1, A W Kors, W E Tjon A Ten, J L Kimpen.   

Abstract

OBJECTIVE: To calculate both medical consumption and socioeconomic effects related to hospitalization for respiratory syncytial virus (RSV) infection in the Netherlands.
METHODS: During the winter seasons of 1998 to 2000, parents of all patients hospitalized for RSV in three secondary care hospitals were asked to fill out questionnaires focusing on the 2 weeks before hospitalization, the period in hospital and the 2 weeks after discharge. The questions concerned workdays lost, level of education and current profession, extra childcare needed, consultation by the family physician and drugs prescribed and costs of travelling.
RESULTS: Seventy-three children were hospitalized. Median age was 79 days (range, 9 to 537 days), and median weight was 5,295 g (range, 3130 to 10,600 g). Three children were born preterm. Parents had 2 (range, 0 to 6) telephone contacts with the family doctor; the child was seen 2 (range, 0 to 4) times before hospitalization. Parents lost 0.5 workday before hospitalization. Duration of hospitalization was 5 days median (range, 1 to 12 days). Parents lost 1.5 (range, 0 to 9) workdays during hospitalization and drove 118 (range, 6 to 550) miles to visit their child. In the period after discharge expenses were negligible. Calculation of all parameters into currency resulted in a total amount of $2,200 per child hospitalized for RSV. Workdays lost, costs for travelling and consultation of family doctors resulted in $295 per child.
CONCLUSIONS: RSV infections necessitating hospitalization in a secondary care hospital have remarkable effects on parental expenses, parental absence from work and medical consumption. On top of the hospital-related costs 15% should be added for parental expenses and socioeconomic costs.

Entities:  

Mesh:

Year:  2001        PMID: 11224834     DOI: 10.1097/00006454-200102000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.

Authors:  Birgit Ehlken; Gabriele Ihorst; Barbara Lippert; Angela Rohwedder; Gudula Petersen; Martin Schumacher; Johannes Forster
Journal:  Eur J Pediatr       Date:  2005-06-18       Impact factor: 3.183

2.  A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

Authors:  Bosco A Paes; Ian Mitchell; Anna Banerji; Krista L Lanctôt; Joanne M Langley
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

Review 3.  Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review.

Authors:  William A Prescott; Fred Doloresco; Jack Brown; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  Changes in Bronchiolitis Incidence During the Last Two Decades in Tampere, Finland: A Retrospective Study.

Authors:  Tytti Vihikangas; Sauli Palmu; Anna-Maija Koivisto; Paula Heikkilä
Journal:  Pediatr Infect Dis J       Date:  2022-07-28       Impact factor: 3.806

5.  Families' costs form a considerable part of total costs in bronchiolitis care.

Authors:  Emilia Mäntynen; Sauli Palmu; Paula Heikkilä
Journal:  Health Sci Rep       Date:  2022-04-26

6.  Prophylaxis of respiratory syncytial virus in Canada in 2003.

Authors:  Joan L Robinson; Bonita E Lee
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

Review 7.  Viral lower respiratory tract infection in infants and young children.

Authors:  J B M van Woensel; W M C van Aalderen; J L L Kimpen
Journal:  BMJ       Date:  2003-07-05

8.  Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants.

Authors:  Maarten O Blanken; Geert W Frederix; Elisabeth E Nibbelke; Hendrik Koffijberg; Elisabeth A M Sanders; Maroeska M Rovers; Louis Bont
Journal:  Eur J Pediatr       Date:  2017-11-22       Impact factor: 3.183

9.  Burden of Respiratory Syncytial Virus Hospitalizations in Canada.

Authors:  Ian Mitchell; Isabelle Defoy; ElizaBeth Grubb
Journal:  Can Respir J       Date:  2017-11-07       Impact factor: 2.409

10.  Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.

Authors:  Evan J Anderson; Xavier Carbonell-Estrany; Maarten Blanken; Marcello Lanari; Margaret Sheridan-Pereira; Barry Rodgers-Gray; John Fullarton; Elisabeth Rouffiac; Pamela Vo; Gerard Notario; Fiona Campbell; Bosco Paes
Journal:  Pediatr Infect Dis J       Date:  2017-02       Impact factor: 2.129

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.